AAPS NBC 2026: Powering Bioanalysis from Discovery to the Clinic
Because Every Moment Matters
Charles River bioanalysis experts welcome you to our booth at the AAPS National Biotechnology Conference (NBC).
This year’s conference centers on two key themes, setting the stage for essential conversations in biotherapeutic development and helping you gain a competitive edge in a fast-moving bioanalytical landscape
Stop by Booth #203 to speak with our experts and learn about our comprehensive bioanalytical solutions across all modalities, and how our expertise helps your teams make confident, timely decisions.
Tuesday, May 12, 2026 | 12:15 p.m. – 1:00 p.m. (PDT)
Efficiency Unlocked: The Case for Single-Well Assessment in Bioanalysis
Speaker: Katherine Malone, Principal Research Scientist, Charles River Lab Sciences
This presentation evaluates single‑well analysis across PK, biomarker, and immunogenicity case studies. A PK assay was intentionally developed and validated for single‑well use, streamlining workflows, increasing throughput, and reducing variability. Biomarker comparisons demonstrated strong concordance between duplicate and single‑well formats. Immunogenicity validation was reprocessed to assess single‑well suitability, with parameter differences examined and rationalized. Collectively, the evidence supports single‑well analysis as a reliable, efficient, cross‑discipline strategy.
| A Universal qPCR Assay for the Quantification of Human DNA in Preclinical Cell Therapy Studies Michael Stone, Research Scientist II, Charles River Cellular Molecular Biology |
| Strategies for Introduction of Single Well Analysis in Ligand Binding Assays Katherine Malone, Principal Research Scientist, Charles River Lab Sciences |
| Singlicate Analysis of an ASO using Hybridization ELISA Technique and Microsampling as part of the 3R's Simon Williams, Senior Research Scientist II, Charles River Immunochemistry - Scientific |
E‑Guide: Strategic Biomarker Solutions from Early Discovery to Clinical Trials
Unlock biomarker strategies that drive clarity and speed, turning integrated planning and real‑time data into stronger decisions, lower risk, and faster development progress.
Download your copy
Faster, Leaner, Smarter: How Modern CROs Accelerate Your Drug Development
Our on‑demand webinar explains how smarter bioanalysis, lean methods, and automation help you overcome potential bottlenecks, delays, and rising costs.
Watch now
E‑Guide: Bioanalysis from Early‑Stage to Clinical Drug Development
This eGuide reveals a smarter bioanalysis strategy that reduces risk and accelerates decisions, aligning science and timelines across development.
Explore the guide